SCHEMBL2346377

SCHEMBL2346377

O=S(=O)(OCC(F)(F)Oc1ccc(F)cc1)C(F)(F)F

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 4/20 0.37
▸ CA1 P00915 3/20 0.36
▸ GAA P10253 1/20 0.36
▸ SOS1 Q07889 1/20 0.35
▸ FFAR1 O14842 1/20 0.35
▸ FFAR4 Q5NUL3 1/20 0.35
▸ PTPN1 P18031 1/20 0.34
▸ AR P10275 1/20 0.34
▸ RORC P51449 2/20 0.33
▸ KIF11 P52732 1/20 0.33
▸ CA12 O43570 1/20 0.33
▸ CA7 P43166 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ PTPRZ1 P23471 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ NR1I2 O75469 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2342755 0.81 ALDH1A1 (0.38) CA2CA1GAAKIF11ALDH1A1
SCHEMBL28038586 0.77 CA2 (0.40) CA2CA1RORCALDH1A1KMT2A
SCHEMBL17583209 0.76 CA2 (0.39) CA2CA1RORCALDH1A1KMT2A
SCHEMBL776070 0.74 CXCR2 (0.45) CA2CA1SOS1FFAR1FFAR4
SCHEMBL7922762 0.73 GAA (0.37) GAAKIF11KMT2A
Phosphine SCHEMBL29104332 0.72 CXCR2 (0.44) CA2CA1SOS1FFAR1FFAR4
Hydrogen Sulfide SCHEMBL27490752 0.72 CXCR2 (0.44) CA2CA1SOS1FFAR1FFAR4
SCHEMBL778365 0.72 CA2 (0.67) CA2CA1ARCA12CA7
SCHEMBL27841648 0.71 PPARG (0.37) CA2CA1SOS1FFAR1FFAR4
Ammonia Solution, Strong SCHEMBL28581052 0.70 CA2 (0.65) CA2CA1ARCA12CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2361243-B9 HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS VIROBAY INC (US) 2014-06-11 — — EP disclosed
EP-2361243-B1 HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS VIROBAY INC (US) 2013-07-03 — — EP disclosed
EP-2361243-A2 HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS Virobay, Inc. (US) 2011-08-31 — — EP disclosed
WO-2010056877-A2 HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS VIROBAY, INC. (US) 2010-05-20 — — WO disclosed
Send feedback